If innovative cancer therapies were the top launches to watch in 2024, this year’s high-profile biopharma debuts is slated to ...

Over her three-decade career, weight management physician Dr. Sarah Ro has seen hundreds of patients. Many of them are on ...

The U.S. Food and Drug Administration said on Friday that it has approved an injectable version of Bristol Myers Squibb's ...

Women's risk of Parkinson's is similar to men's - but they are much more likely to be misdiagnosed, with serious consequences ...

Today we’re examining a concerning development in the spread of bird flu in the US. But first: Even though Peter Yarrow ...

A range of GLP-1 weight loss drugs are currently on the market. What are they, what do they do, and where are they available?

We recently compiled a list of the 12 Best Penny Stocks to Invest in According to the Media. In this article, we are going to ...

Healthcare experts have listed funding, corporate investments, and other factors as priorities to drive economic growth in Nigeria's healthcare sector ...

Four states now allow government-run insurance programs to cover Native American healing practices. In October, the Biden ...

The Food and Drug Administration has approved Unloxcyt (cosibelimab-ipdl) for advanced cutaneous squamous cell carcinoma.

The FDA granted priority review to a new drug application for sunvozertinib as an oral treatment for certain patients with ...